Pulmonary hypertension (PH), defined by increased pressure within the pulmonary
vasculature, is a hemodynamic and pathophysiologic state present in a wide variety of …

Abstract Background Three‐dimensional (3D) echocardiography and 2‐dimensional (2D)
strain measurements of the right ventricle (RV) are important indices in humans with …

Cardiomyopathies remain as one of the most common inherited cardiac diseases in both
human and veterinary patients. 1–3 These adult-onset cardiac disorders are characterized …

A 1, 5-year-old male Maltipoo was presented to the emergency service for dyspnea,
weakness, and cough. An echocardiographic examination showed evidence of pulmonary …

Background Pulmonary hypertension (PH) secondary to respiratory disease is caused by
pulmonary vascular remodeling and hypoxia. Severe PH can induce various clinical signs …

Pulmonary hypertension (PH) is a common clinical condition associated with morbidity and
mortality in both humans and dogs. Sildenafil, a phosphodiesterase-5 (PDE5) inhibitor …

Dogs with respiratory disease can develop pulmonary hypertension (PH), a comorbid
condition that can impact therapy and prognosis. Without confirmation using the criterion …

Introduction Pulmonary hypertension (PH) is a progressive and potentially life-threatening
disease. Several drugs are used for the treatment of dogs with precapillary PH. Pimobendan …

Materials and Methods: Fourteen dogs diagnosed with PH secondary to DMVD Stage C on
conventional therapy were randomly assigned to placebo (n= 7) and sildenafil (n= 7) …

Sedation and general anesthesia produce profound changes in respiratory function, with the
degree of change depending on drugs employed, species involved, depth of anesthesia …